Push Health vs Wisp
Wisp costs $851 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Push Health and Wisp, the first difference is cost: Wisp is $851 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Wisp leads our six-part score, 6.5 to 5.6.
Push Health vs Wisp price
Wisp is the cheaper way in: $99 a month against $950 a month at Push Health. That is $851 less each month (90% lower), or about $10,212 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Wisp ($225 a month vs $950 a month).
Medications and formats
Both sell semaglutide; only Wisp lists tirzepatide.
On format, Push Health prices brand-name pens, while Wisp prices compounded injections and brand-name pens.
Where each one treats patients
Neither Push Health nor Wisp publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Push Health
Ozempic / brand
Wisp
Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.
Zepbound $99/mo (compounded sublingual semaglutide $225/mo)
What each price covers
Wisp's price also covers the medication itself and shipping, which Push Health does not claim.
Push Health does not say what its price includes.
Wisp is silent on the clinician visit, lab work and coaching.
That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.
Push Health
Inclusions not disclosed.
Wisp
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Wisp scores 6.5 and Push Health 5.6 out of 10.
Push Health is stronger on value (5.3 vs 3.5) and support (5.0 vs 4.5).
Wisp is stronger on effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0) and trust & safety (6.5 vs 4.0).
Accessibility is within half a point.
Push Health
5.6/10
Wisp
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Push Health nor Wisp has an FDA warning letter on record with us.
Features & Coverage
| Feature | Push Health | Wisp |
|---|---|---|
| Starting Price | $950/mo | ✓$99/mo |
| Features | 5 features | ✓8 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →About Wisp
$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.
Read our full Wisp review →Pros & Cons
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Wisp
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Wisp
Watch-outs
- Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Wisp wins this one, 6.5 to 5.6, above all for an oral route if you will not self-inject. It also costs $851 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Choose Wisp if…
You want an oral route if you will not self-inject and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Push Health vs Wisp: FAQ
Close alternatives to Push Health and Wisp
- Push Health vs JumpstartMD
- Push Health vs Marek Health
- Push Health vs Cost Plus Drugs
- Push Health vs Medi-Weightloss
- Wisp vs GobyMeds
- Wisp vs HeliMeds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.